DE69906859T2 - Neue Reagenzien und Methoden zur Lyse von Erythrozyten - Google Patents

Neue Reagenzien und Methoden zur Lyse von Erythrozyten Download PDF

Info

Publication number
DE69906859T2
DE69906859T2 DE69906859T DE69906859T DE69906859T2 DE 69906859 T2 DE69906859 T2 DE 69906859T2 DE 69906859 T DE69906859 T DE 69906859T DE 69906859 T DE69906859 T DE 69906859T DE 69906859 T2 DE69906859 T2 DE 69906859T2
Authority
DE
Germany
Prior art keywords
methods
lysing
lysing erythrocytes
new reagents
nitrogen containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69906859T
Other languages
English (en)
Other versions
DE69906859D1 (de
Inventor
Agthoven Andre Van
David Jarrossay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunotech SAS
Original Assignee
Immunotech SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunotech SAS filed Critical Immunotech SAS
Application granted granted Critical
Publication of DE69906859D1 publication Critical patent/DE69906859D1/de
Publication of DE69906859T2 publication Critical patent/DE69906859T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/101666—Particle count or volume standard or control [e.g., platelet count standards, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/107497—Preparation composition [e.g., lysing or precipitation, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331—Preservative, buffer, anticoagulant or diluent

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Ecology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69906859T 1998-05-07 1999-05-04 Neue Reagenzien und Methoden zur Lyse von Erythrozyten Expired - Lifetime DE69906859T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9806055A FR2778413B1 (fr) 1998-05-07 1998-05-07 Nouveaux reactifs et methode de lyse des erythrocytes

Publications (2)

Publication Number Publication Date
DE69906859D1 DE69906859D1 (de) 2003-05-22
DE69906859T2 true DE69906859T2 (de) 2004-01-29

Family

ID=9526319

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69906859T Expired - Lifetime DE69906859T2 (de) 1998-05-07 1999-05-04 Neue Reagenzien und Methoden zur Lyse von Erythrozyten
DE0955543T Pending DE955543T1 (de) 1998-05-07 1999-05-04 Neue Reagenzien und Methoden zur Lyse von Erythrozyten

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE0955543T Pending DE955543T1 (de) 1998-05-07 1999-05-04 Neue Reagenzien und Methoden zur Lyse von Erythrozyten

Country Status (11)

Country Link
US (1) US6143567A (de)
EP (1) EP0955543B1 (de)
JP (2) JPH11352125A (de)
AT (1) ATE237806T1 (de)
AU (1) AU747910B2 (de)
DE (2) DE69906859T2 (de)
ES (1) ES2141073T1 (de)
FR (1) FR2778413B1 (de)
GR (1) GR990300041T1 (de)
NO (1) NO992206L (de)
NZ (1) NZ335594A (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2813891B1 (fr) * 2000-09-14 2005-01-14 Immunotech Sa Reactif multifonctionnel pour erythrocytes mettant en jeu des carbamates et applications
US7465584B2 (en) * 2005-01-24 2008-12-16 Sysmex Corporation Method and reagent for classifying leukocytes in animal blood
EP3035798B1 (de) * 2013-08-20 2018-09-19 Yeditepe Universitesi Kryokonservierungsmedium für zellen mit borzusatz
WO2015191508A1 (en) 2014-06-09 2015-12-17 Voyager Therapeutics, Inc. Chimeric capsids
EP3215191A4 (de) 2014-11-05 2018-08-01 Voyager Therapeutics, Inc. Aadc-polynukleotide zur behandlung von morbus parkinson
SG11201703419UA (en) 2014-11-14 2017-05-30 Voyager Therapeutics Inc Modulatory polynucleotides
CN107109407A (zh) 2014-11-14 2017-08-29 沃雅戈治疗公司 治疗肌萎缩性侧索硬化(als)的组合物和方法
US11697825B2 (en) 2014-12-12 2023-07-11 Voyager Therapeutics, Inc. Compositions and methods for the production of scAAV
US20180230489A1 (en) 2015-10-28 2018-08-16 Voyager Therapeutics, Inc. Regulatable expression using adeno-associated virus (aav)
US10215683B2 (en) 2015-11-02 2019-02-26 Chiranjit Deka Light scatter based apparatus and methods for hematology analysis using only three detectors
WO2017189964A2 (en) 2016-04-29 2017-11-02 Voyager Therapeutics, Inc. Compositions for the treatment of disease
WO2017189959A1 (en) 2016-04-29 2017-11-02 Voyager Therapeutics, Inc. Compositions for the treatment of disease
CN110214187B (zh) 2016-05-18 2024-01-30 沃雅戈治疗公司 调节性多核苷酸
CA3024449A1 (en) 2016-05-18 2017-11-23 Voyager Therapeutics, Inc. Compositions and methods of treating huntington's disease
US11298041B2 (en) 2016-08-30 2022-04-12 The Regents Of The University Of California Methods for biomedical targeting and delivery and devices and systems for practicing the same
WO2018048586A1 (en) * 2016-09-06 2018-03-15 Chiranjit Deka Improved reagent and method for identification and enumeration of basophils
SG11201909868YA (en) 2017-05-05 2019-11-28 Voyager Therapeutics Inc Compositions and methods of treating huntington's disease
EP3618839A4 (de) 2017-05-05 2021-06-09 Voyager Therapeutics, Inc. Zusammensetzungen und verfahren zur behandlung von amyotropher lateralsklerose (als)
WO2018220835A1 (ja) * 2017-06-02 2018-12-06 日立化成株式会社 血液試料中の希少細胞を分離する方法及び該細胞の遺伝子を解析する方法
JOP20190269A1 (ar) 2017-06-15 2019-11-20 Voyager Therapeutics Inc بولي نوكليوتيدات aadc لعلاج مرض باركنسون
CN111132626B (zh) 2017-07-17 2024-01-30 沃雅戈治疗公司 轨迹阵列引导系统
WO2019028306A2 (en) 2017-08-03 2019-02-07 Voyager Therapeutics, Inc. COMPOSITIONS AND METHODS FOR ADMINISTRATION OF ADENO-ASSOCIATED VIRUSES
EP3441763A1 (de) 2017-08-08 2019-02-13 Euroimmun Medizinische Labordiagnostika AG Verfahren zum nachweis einer basophilenaktivierung
BR102018015288A2 (pt) 2017-08-08 2021-11-09 Euroimmun Medizinische Labordiagnostika Ag Método para comprovar uma ativação de basófilos
AU2018352236A1 (en) 2017-10-16 2020-04-23 The Curators Of The University Of Missouri Treatment of amyotrophic lateral sclerosis (ALS)
WO2019079242A1 (en) 2017-10-16 2019-04-25 Voyager Therapeutics, Inc. TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)
WO2019173434A1 (en) 2018-03-06 2019-09-12 Voyager Therapeutics, Inc. Insect cell manufactured partial self-complementary aav genomes
WO2019222444A2 (en) 2018-05-16 2019-11-21 Voyager Therapeutics, Inc. Directed evolution
US20210207167A1 (en) 2018-05-16 2021-07-08 Voyager Therapeutics, Inc. Aav serotypes for brain specific payload delivery
WO2020010042A1 (en) 2018-07-02 2020-01-09 Voyager Therapeutics, Inc. Treatment of amyotrophic lateral sclerosis and disorders associated with the spinal cord
AU2019310459A1 (en) 2018-07-24 2021-02-18 Voyager Therapeutics, Inc. Systems and methods for producing gene therapy formulations
WO2020072849A1 (en) 2018-10-04 2020-04-09 Voyager Therapeutics, Inc. Methods for measuring the titer and potency of viral vector particles
JP2022522995A (ja) 2019-01-18 2022-04-21 ボイジャー セラピューティクス インコーポレイテッド Ａａｖ粒子を生成するための方法及びシステム
WO2020223274A1 (en) 2019-04-29 2020-11-05 Voyager Therapeutics, Inc. SYSTEMS AND METHODS FOR PRODUCING BACULOVIRAL INFECTED INSECT CELLS (BIICs) IN BIOREACTORS
US20220290182A1 (en) 2019-08-09 2022-09-15 Voyager Therapeutics, Inc. Cell culture medium for use in producing gene therapy products in bioreactors
TW202122582A (zh) 2019-08-26 2021-06-16 美商航海家醫療公司 病毒蛋白之控制表現
CN111504887B (zh) * 2020-05-09 2023-05-09 苏州四正柏生物科技有限公司 一种溶血素及其制备方法
US20230295656A1 (en) 2020-08-06 2023-09-21 Voyager Therapeutics, Inc. Cell culture medium for use in producing gene therapy products in bioreactors
WO2022187473A2 (en) 2021-03-03 2022-09-09 Voyager Therapeutics, Inc. Controlled expression of viral proteins
US20240141378A1 (en) 2021-03-03 2024-05-02 Voyager Therapeutics, Inc. Controlled expression of viral proteins
WO2024054983A1 (en) 2022-09-08 2024-03-14 Voyager Therapeutics, Inc. Controlled expression of viral proteins

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3884579A (en) * 1973-06-14 1975-05-20 Cambridge Chemical Products In Method for counting blood platelets
US4284412A (en) * 1979-07-13 1981-08-18 Ortho Diagnostics, Inc. Method and apparatus for automated identification and enumeration of specified blood cell subclasses
US4637986A (en) * 1983-08-22 1987-01-20 Ortho Diagnostic Systems, Inc. Flow cytometry lysing reagent with leukoprotective agent for producing a 3-part WBC count
US4902613A (en) * 1984-05-14 1990-02-20 Becton, Dickinson And Company Lysing agent for analysis of peripheral blood cells
US5188935A (en) * 1984-05-31 1993-02-23 Coulter Electronics, Inc. Reagent system and method for identification, enumeration and examination of classes and subclasses of blood leukocytes
JP2836865B2 (ja) * 1989-10-23 1998-12-14 東亜医用電子株式会社 血液中の白血球およびヘモグロビンの測定用試薬
US5316951A (en) * 1991-06-07 1994-05-31 Carver Jr Edward L Method for the improved determination of white blood cell subpopulations
JP3177863B2 (ja) * 1992-07-17 2001-06-18 東ソー株式会社 不安定型糖化ヘモグロビンの除去方法
AU6235994A (en) * 1993-02-25 1994-09-14 Abbott Laboratories Multipurpose reagent system for rapid lysis of whole blood samples
FR2705359B1 (fr) * 1993-05-19 1995-08-18 Immunotech Sa Méthode de protection des cellules leucocytaires, composition protectrice, composition de sang protégée, et méthode d'analyse sanguine.
FR2705360B1 (fr) * 1993-05-19 1995-08-18 Immunotech Sa Méthode et composition pour la lyse des érythrocytes, composition de sang, et méthode d'analyse leucocytaire.
JPH08189924A (ja) * 1994-03-07 1996-07-23 Sekisui Chem Co Ltd 安定型糖化ヘモグロビンの測定方法
JP3324050B2 (ja) * 1994-10-31 2002-09-17 日本光電工業株式会社 白血球分類用試薬および白血球分類方法
US5763280A (en) * 1997-01-21 1998-06-09 Coulter International Corp. Cyanide-free lytic reagent composition and method for hemoglobin and cell analysis
JP3830613B2 (ja) * 1997-04-18 2006-10-04 シスメックス株式会社 血液中の白血球及びヘモグロビン濃度測定試薬
EP1029872A4 (de) * 1997-11-07 2001-05-02 Daiichi Seiyaku Co Komplexe von piperazin und cyclodextrin

Also Published As

Publication number Publication date
NO992206D0 (no) 1999-05-06
AU747910B2 (en) 2002-05-30
AU2698499A (en) 2000-04-13
ES2141073T1 (es) 2000-03-16
FR2778413A1 (fr) 1999-11-12
ATE237806T1 (de) 2003-05-15
FR2778413B1 (fr) 2000-08-04
EP0955543B1 (de) 2003-04-16
NO992206L (no) 1999-11-08
DE955543T1 (de) 2000-06-08
EP0955543A1 (de) 1999-11-10
NZ335594A (en) 2000-02-28
JP2008224696A (ja) 2008-09-25
JPH11352125A (ja) 1999-12-24
JP4446059B2 (ja) 2010-04-07
US6143567A (en) 2000-11-07
DE69906859D1 (de) 2003-05-22
GR990300041T1 (en) 2000-01-31

Similar Documents

Publication Publication Date Title
DE69906859T2 (de) Neue Reagenzien und Methoden zur Lyse von Erythrozyten
ATE450794T1 (de) Carbamatenthaltendes multifunktionelles erythrozytenreagenz und verwendungen
ATE36457T1 (de) Verfahren zur inaktivierung von vermehrungsfaehigen krankheitserregern.
ATE83561T1 (de) Denaturierende reagenzien zur bestimmung von haemoglobinderivaten im blut.
DE3751109T2 (de) Reagenzien zur Bestimmung von Peptidoglykan und beta-1,3-Glukan.
DE69903236D1 (de) Reagenz zum Assay von Hämoglobin und zur Bestimmung der Leukozyten in einer Blutprobe
PT696642E (pt) Processo para a identificacao de pertuebacoes do sistema proteina c / proteina s
ES516496A0 (es) "procedimiento para la determinacion de hemoglobina glucosilada".
DE3784528D1 (de) Zusammensetzung und verfahren zur stabilisierung von dinukleotiden.
DE69029291D1 (de) Verwendung von Lithiumsalzen zur Lysis von Erythrozyten und zur Denaturierung von Hämoglobin
DK56386A (da) Reagens til ved haemagglunitation at bestemme antistoffer mod bakterielle toksiner, fremgangsmaade til fremstilling af reagenset og dettes anvendelse
DE3765147D1 (de) Verfahren und reagenz zur bestimmung von gesamt-bilirubin.
EP1607742A4 (de) Latex-reaktionsmittel zur adiponectinanalyse und verfahren zur adiponectinanalyse
ATE80665T1 (de) Verfahren und reagens zur bestimmung von ld-1isoenzym.
ES2084628T3 (es) Metodo enzimatico para determinar las concentraciones del producto analizado.
ATE225936T1 (de) Reagenz und methode zur permeabilisierung und zur identifizierung von erythrozyten
DE69420311T2 (de) Verfahren und Zusammensetzung zum Lysieren von Erythrozyten, Blutzusammensetzungen und Verfahren zur Leukozytanalyse
DE59205827D1 (de) Verfahren zur Bestimmung von Fibrin
DE60024923D1 (de) Verfahren zur Analyse der funktionellen Aktivierung von Leukocyten, Plättchen und anderen Zellen
GEP19970879B (en) Method for Determining Lead Contents in blood

Legal Events

Date Code Title Description
8364 No opposition during term of opposition